Loading...

Hisun operates a globally integrated network of 4 manufacturing facilities. Our best-in-class facilities are built to manufacture and deliver a wide range of active pharmaceutical products (API) and finished dose products, to more than 60 countries. All facilities follow strict quality, safety, and environmental standards as upheld and outlined by government bodies and leading regulators such as US FDA, EMA, TGA and others.

 For more information, please contact:

Peggy Albanese
Director Business Development and Sales
Hisun Pharmaceuticals USA, Inc.
212 Carnegie Center, Suite 302
Princeton, NJ 08540-6236
Office: 609-454-0237
Email: Peggy.Albanese@hisunusa.com

 

Solid Dosage Capacity

Pilot Plant

Production Plant

 

API Manufacturing Capacity

Chemical Synthesis

Fermentation

 

Injectable Capacity

Lyophillization

    The largest Capacity in China for lyphillization of sterile pharmaceuticals

Filling

  • Gravimetrically controlled fill checks
  • Low particle aseptic techniques
  • Protection of photosensetive products
  • Inert headspace atmosephere in the container
  • Automatic stoppering and traying

 

Biologics

Mammalian and microbial 

 

Animal Health

Capacities

  • Injection(Suspension) 
  • Injection
  • Intramammary infusion 
  • Oral solution / Shampoo 
  • Toothpaste / premix 
  • Tablets / premix

 

 

;